Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 54 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

32Total
Not Applicable (12)
Early P 1 (1)
P 1 (9)
P 2 (8)
P 3 (2)

Trial Status

Recruiting27
Not Yet Recruiting19
Completed5
Active Not Recruiting3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (54)

Showing 20 of 20 trials
NCT07740642Not Yet RecruitingPrimary

A Comparative Usability Study of Two Total Body Skin Imaging Systems

NCT07680452Not ApplicableRecruitingPrimary

Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhibition

NCT07686835Phase 2Recruiting

Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.

NCT07689812Not ApplicableNot Yet Recruiting

A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

NCT07718243Phase 1Not Yet RecruitingPrimary

Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC

NCT07287917Phase 1RecruitingPrimary

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

NCT07341737Phase 1Recruiting

SL-28 for Advanced Solid Tumours

NCT07556380Not ApplicableRecruitingPrimary

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

NCT07691255Not Yet RecruitingPrimary

MELanoma Brain Metastasis Treated With CYberknife

NCT07280715Not ApplicableRecruiting

Investigating Real-Time Immunotherapy Symptoms Study

NCT07406087Not ApplicableRecruiting

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

NCT07327489Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

NCT07649681Not ApplicableNot Yet Recruiting

Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention

NCT07670403Completed

Digital Phenotyping of Psychological Distress in Skin Cancer Patients

NCT07661966Not ApplicableNot Yet RecruitingPrimary

Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

NCT07653087Not ApplicableNot Yet Recruiting

Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma

NCT07651618Phase 2Not Yet RecruitingPrimary

A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic Melanoma

NCT07619898Phase 2Not Yet Recruiting

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

NCT07615881Phase 1Not Yet RecruitingPrimary

Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With Melanoma

NCT06608511Active Not Recruiting

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Scroll to load more

Research Network

Activity Timeline